AOL Money & Finance

Option update: PDL BioPharma no longer pursuing sale of company

More

PDL BioPharma (NYSE: PDLI) announced it will no longer actively pursue the sale of the company or its biotechnology discovery and development assets.

PDLI is recently down $2.96 to $12.88 in pre-open trading.

PDLI overall option implied volatility of 41 is above its 26-week average of 37 according to Track Data, suggesting slightly larger price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Symbol Lookup
IndexesChangePrice
DJIA+30.6910,464.40
NASDAQ+6.872,176.05
S&P 500+4.981,110.63

Last updated: November 26, 2009: 04:08 AM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

TheFlyOnTheWall.com Headlines

    BioHealth Investor Headlines

    WalletPop Headlines

    My Portfolios

    Track your stocks here!

    Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

    BloggingStocks Partners

    More from AOL Money & Finance

    WalletPop Headlines